DNA X, Inc. SONM
We are a provider of crypto trading services to the public. Our services are available over the internet at www.dnax.us.
We serve individual cryptocurrency traders around the world. Our products allow users to efficiently buy and sell cryptocurrencies with
cash or cash equivalents, or to exchange one cryptocurrency for another cryptocurrency. Our platform allows users to execute strategies
between pairs of cryptocurrencies that allow them to swap between the currencies as the prices diverge or converge. This allows users
Last close
3.08
2026-10-23
Market cap
$4.6M
2026-06-30 share count
52-week range
2.52 - 12.30
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-28.58
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $50.9M | $93.6M | $69.8M | $54.6M | $64.0M | $116.3M | $135.7M | — |
| Cost of revenue | — | $48.4M | $74.3M | $58.2M | $48.2M | $48.8M | $81.7M | $87.6M | — |
| Gross profit | — | $9.9M | $19.3M | $11.6M | $6.4M | $15.2M | $34.5M | $48.1M | — |
| R&D | — | $14.2M | $1.8M | $8.0M | $17.7M | $16.2M | $26.1M | $23.2M | — |
| SG&A | $5.4M | $3.1M | $8.3M | $10.7M | $10.3M | $9.8M | $15.1M | $7.2M | — |
| Total operating expenses | $5.4M | $3.1M | $18.8M | $25.9M | $44.4M | $44.5M | $56.9M | $42.7M | — |
| Operating income | -$5.4M | -$3.1M | $513.0K | -$14.3M | -$38.0M | -$29.3M | -$22.4M | $5.4M | — |
| Interest expense | $945.0K | — | — | $97.0K | — | — | — | — | — |
| Pre-tax income | -$8.0M | -$2.9M | $284.0K | -$13.9M | -$38.5M | -$30.5M | -$24.4M | $2.0M | — |
| Income tax | $1.1M | $226.0K | $374.0K | $184.0K | $167.0K | $521.0K | $1.4M | $754.0K | — |
| Net income | -$20.7M | -$33.6M | -$90.0K | -$14.1M | -$38.6M | -$29.9M | -$25.8M | $1.3M | — |
| EPS, basic | -28.58 | -128.37 | -0.02 | -0.49 | -4.08 | — | — | — | — |
| EPS, diluted | -28.58 | -128.37 | -0.02 | -0.49 | -4.08 | -6.48 | -1.39 | -2.57 | — |
| Shares, diluted (wtd. avg.) | 722,689 | 262,118 | 4.3M | 28.9M | 9.5M | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.3M | $5.3M | $9.4M | $13.2M | $11.2M | $22.1M | $11.3M | $13.0M | — |
| Receivables | — | $4.3M | $25.3M | $22.4M | $10.8M | $4.2M | $10.1M | $18.9M | — |
| Inventory | — | $10.6M | $6.5M | $3.9M | $5.5M | $11.3M | $19.5M | $21.8M | — |
| Total current assets | $28.9M | $32.2M | $43.8M | $43.6M | $35.7M | $45.6M | $47.3M | $63.9M | — |
| Property, plant and equipment | — | $227.0K | $71.0K | $168.0K | $534.0K | $843.0K | $1.4M | $1.1M | — |
| Total assets | $43.9M | $39.7M | $56.0M | $53.7M | $41.1M | $50.3M | $55.5M | $67.3M | — |
| Accounts payable | $4.0M | $738.0K | $19.8M | $21.1M | $9.5M | $8.9M | $7.2M | $27.3M | — |
| Short-term debt | $5.1M | — | — | $147.0K | $148.0K | $177.0K | $9.8M | $301.0K | — |
| Total current liabilities | $48.0M | $43.7M | $32.1M | $32.1M | $21.0M | $20.5M | $27.6M | $48.2M | — |
| Long-term debt | $5.1M | — | — | — | $66.0K | $185.0K | $362.0K | $13.2M | — |
| Total liabilities | $50.6M | $45.4M | $33.7M | $33.6M | $22.5M | $21.9M | $29.9M | $62.2M | — |
| Retained earnings | -$304.3M | -$283.6M | -$250.0M | -$249.9M | -$234.8M | -$196.2M | -$166.2M | -$143.5M | — |
| Total equity | -$8.0M | -$5.7M | $22.4M | $20.0M | $18.6M | $28.4M | $25.5M | $5.1M | -$89.9M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$23.5M | -$8.5M | -$4.1M | -$12.4M | -$38.5M | -$10.6M | -$33.5M | $3.9M | — |
| Depreciation and amortisation | — | $58.0K | $47.0K | $244.0K | $301.0K | $2.7M | $3.5M | $1.9M | — |
| Stock-based compensation | $1.5M | $1.5M | $1.5M | $1.6M | $1.1M | $1.1M | $6.3M | $252.0K | — |
| Capital expenditure | — | $214.0K | $36.0K | $8.0K | $46.0K | $11.0K | $992.0K | $787.0K | — |
| Investing cash flow | — | -$214.0K | -$36.0K | -$8.0K | -$46.0K | -$11.0K | -$1.4M | -$2.5M | — |
| Financing cash flow | $19.5M | $4.6M | $272.0K | $14.3M | $27.6M | $21.4M | $33.1M | $10.2M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-020421.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $135.7M | $116.3M | $64.0M | $54.6M | $69.8M | $93.6M | $50.9M | — |
| Gross profit | — | $48.1M | $34.5M | $15.2M | $6.4M | $11.6M | $19.3M | $9.9M | — |
| Net income | — | $1.3M | -$25.8M | -$29.9M | -$38.6M | -$14.1M | -$90.0K | -$33.6M | -$20.7M |
Recent filings and events
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Other event Item 8.01
- Unregistered share sale Item 3.02
- Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Other event Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Unregistered share sale Item 3.02
- Shareholder rights changed Item 3.03
- Charter or fiscal year changed Item 5.03
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3661
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| CIEN | CIENA CORP | $45.42B | 376.8x | 18.8% |
| FN | Fabrinet | $11.29B | 24.1x | 35.7% |
| ADTN | ADTRAN Holdings, Inc. | $523.9M | — | 17.5% |
| CLFD | Clearfield, Inc. | $376.3M | — | 19.6% |
| FIEE | FiEE, Inc. | $26.9M | 31.5x | 867.9% |
| FKWL | FRANKLIN WIRELESS CORP | $25.9M | — | 49.6% |
| CLRO | CLEARONE INC | $8.7M | — | — |
| AUDC | AUDIOCODES LTD | — | — | 1.4% |